Skip to content

Swixx Biopharma expands to South America

With an additional revenue volume of US$220 million, more than 300 new employees, and therapeutic coverage in the fields of neurology, oncology, immunology, gastroenterology, rare diseases, and specialties, the acquisition expands and transforms Swixx BioPharma's market presence. The acquisition has immediate positive effects, creating a compelling one-stop shop and multiregional [...]

SWIXX BIOPHARMA EXPANDS TO LATIN AMERICA THROUGH STRATEGIC ACQUISITION AND MERGER WITH BIOPAS
author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu